Visit
VJHemOnc is excited to present the latest developments in the role of chemotherapy across lymphomas
VJHemOnc is pleased to bring you a feature exploring theĀ emerging applications of MRD in multiple myeloma.
VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials…
VJHemOnc is pleased to bring you a feature exploring the latest developments in the treatment of NHL, with leading experts…
VJHemOnc is excited to bring you the latest updates from the 2022 third annual Texas MPN Workshop, which brought together…
Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.
VJHemOnc is excited to bring you the latest updates fromĀ The Texas MPN Workshop: Second Annual Workshop and Meeting, which brought…
VJHemOnc was official Media Partner for the ERIC 2020 Virtual Meeting, New Frontiers in CLL Research, which took place on 1-3…
VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!
Published in Blood, a special report has proposed a new, distinct subtype of myelodysplastic syndromes (MDS) based on the presence…
Chimeric antigen receptor T-cell (CAR-T) therapies have proven particularly successful in hematological malignancies. However, CAR T-cells still underperform when used…
VJHemOnc is pleased to bring e-learning webcasts from iwNHL 2018- explore updates in lymphoma!
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter